Literature DB >> 26543596

MitraClip-data analysis of contemporary literature.

Florian Deuschl1, Niklas Schofer1, Edith Lubos1, Johannes Schirmer1, Lenard Conradi1, Hendrik Treede1, Hermann Reichenspurner1, Stefan Blankenberg1, Ulrich Schäfer1.   

Abstract

Treatment of mitral regurgitation (MR) with the MitraClip (MC), a percutaneous, transseptal edge-to-edge reconstruction of the mitral valve, has become an interesting treatment option in most patients not eligible for surgery. Lately a variety of studies have been published analyzing the treatment of MR with the MC in degenerative as well as functional MR. The results for both entities of MR show negligible intraprocedural mortality, low periprocedural complications rates and a beneficiary outcome in terms of reduction in MR as well as an improvement in functional capacity and quality of life. Here we summarize the latest results focusing on safety and efficacy of MC treatment.

Entities:  

Keywords:  MitraClip (MC); percutaneous mitral valve repair; safety outcome

Year:  2015        PMID： 26543596      PMCID： PMC4598489          DOI： 10.3978/j.issn.2072-1439.2015.07.38

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  45 in total

1.  Gender-related clinical and echocardiographic outcomes at 30-day and 12-month follow up after MitraClip implantation in the GRASP registry.

Authors:  Guilherme F Attizzani; Yohei Ohno; Davide Capodanno; Stefano Cannata; Fabio Dipasqua; Sebastiano Immé; Sarah Mangiafico; Marco Barbanti; Margherita Ministeri; Anna Cageggi; Anna Maria Pistritto; Sandra Giaquinta; Silvia Farruggio; Marta Chiarandà; Giuseppe Ronsivalle; Salvatore Scandura; Corrado Tamburino; Piera Capranzano; Carmelo Grasso
Journal:  Catheter Cardiovasc Interv       Date:  2014-11-10       Impact factor: 2.692

2.  Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the "edge-to-edge" technique.

Authors:  Michele De Bonis; Elisabetta Lapenna; Giovanni La Canna; Eleonora Ficarra; Marco Pagliaro; Lucia Torracca; Francesco Maisano; Ottavio Alfieri
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

3.  Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy.

Authors:  Paul A Grayburn; Elyse Foster; Chithra Sangli; Neil J Weissman; Joseph Massaro; Donald G Glower; Ted Feldman; Laura Mauri
Journal:  Circulation       Date:  2013-09-06       Impact factor: 29.690

4.  One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry).

Authors:  Carmelo Grasso; Davide Capodanno; Salvatore Scandura; Stefano Cannata; Sebastiano Immè; Sarah Mangiafico; Anna Pistritto; Margherita Ministeri; Marco Barbanti; Anna Caggegi; Marta Chiarandà; Fabio Dipasqua; Sandra Giaquinta; Michele Occhipinti; Gianpaolo Ussia; Corrado Tamburino
Journal:  Am J Cardiol       Date:  2013-02-20       Impact factor: 2.778

5.  MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry.

Authors:  Stephan Baldus; Wolfgang Schillinger; Olaf Franzen; Raffi Bekeredjian; Horst Sievert; Joachim Schofer; Karl-Heinz Kuck; Thomas Konorza; Helge Möllmann; Christoph Hehrlein; Taoufik Ouarrak; Jochen Senges; Thomas Meinertz
Journal:  Eur J Heart Fail       Date:  2012-06-08       Impact factor: 15.534

6.  Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study.

Authors:  Patrick L Whitlow; Ted Feldman; Wes R Pedersen; D Scott Lim; Robert Kipperman; Richard Smalling; Tanvir Bajwa; Howard C Herrmann; John Lasala; James T Maddux; Murat Tuzcu; Samir Kapadia; Alfredo Trento; Robert J Siegel; Elyse Foster; Donald Glower; Laura Mauri; Saibal Kar
Journal:  J Am Coll Cardiol       Date:  2012-01-10       Impact factor: 24.094

7.  Percutaneous edge-to-edge repair of mitral regurgitation as a bail-out strategy in critically ill patients.

Authors:  Sven T Pleger; Emmanuel Chorianopoulos; Ulrike Krumsdorf; Hugo A Katus; Raffi Bekeredjian
Journal:  J Invasive Cardiol       Date:  2013-02       Impact factor: 2.022

8.  Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip® device in the ACCESS-EUrope Phase I trial.

Authors:  Hermann Reichenspurner; Wolfgang Schillinger; Stephan Baldus; Jörg Hausleiter; Christian Butter; Ulrich Schäefer; Giovanni Pedrazzini; Francesco Maisano
Journal:  Eur J Cardiothorac Surg       Date:  2013-07-17       Impact factor: 4.191

9.  Failure of acute procedural success predicts adverse outcome after percutaneous edge-to-edge mitral valve repair with MitraClip.

Authors:  Miriam Puls; Tobias Tichelbäcker; Annalen Bleckmann; Mark Hünlich; Katrin von der Ehe; Bo Eric Beuthner; Karin Rüter; Tim Beißbarth; Ralf Seipelt; Friedrich Schöndube; Gerd Hasenfuß; Wolfgang Schillinger
Journal:  EuroIntervention       Date:  2014       Impact factor: 6.534

10.  Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry.

Authors:  Wolfgang Schillinger; Mark Hünlich; Stephan Baldus; Taoufik Ouarrak; Peter Boekstegers; Ulrich Hink; Christian Butter; Raffi Bekeredjian; Björn Plicht; Horst Sievert; Joachim Schofer; Jochen Senges; Thomas Meinertz; Gerd Hasenfuß
Journal:  EuroIntervention       Date:  2013-05-20       Impact factor: 6.534
View more
  1 in total

1.  Short-term and 1-year outcomes after MitraClip therapy in functional versus degenerative mitral regurgitation patients: a systematic review and meta-analysis.

Authors:  Xiao-Hang Liu; Jia-Yu Shi; Xiao-Jin Feng; Dong-Cai Feng; Lin Wang; Hai-Yu Pang; Hong-Zhi Xie; Fang-Fei Wang; Jeffrey Hsu; Fu-Wei Jia; Wei Chen
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.